INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia

Leukemia
I DzneladzeL Salmena

Abstract

In this study, we investigated the role of inositol polyphosphate-4-phosphatase, type-II (INPP4B) in acute myeloid leukemia (AML). We observed that AML patients with high levels of INPP4B (INPP4B(high)) had poor response to induction therapy, shorter event-free survival and shorter overall survival. Multivariate analyses demonstrated that INPP4B(high) was an independent predictor of poor prognosis, significantly improving current predictive models, where it outperformed conventional biomarkers including FLT3-ITD and NPM1. Furthermore, INPP4B(high) effectively segregated relative risk in AML patients with normal cytogenetics. The role of INPP4B on the biology of leukemic cells was assessed in vitro. Overexpression of INPP4B in AML cell lines enhanced colony formation potential, recapitulated the chemotherapy resistance observed in AML patients and promoted proliferation in a phosphatase-dependent, and Akt-independent manner. These findings reveal that INPP4B(high) has an unexpected role consistent with oncogenesis in AML, in contrast to its previously reported tumor-suppressive role in epithelial cancers. Overall, we propose that INPP4B is a novel prognostic biomarker in AML that has potential to be translated into clinical prac...Continue Reading

References

Sep 30, 1999·The New England Journal of Medicine·B LöwenbergA Burnett
Jun 18, 2005·Cell·Thomas F WestbrookStephen J Elledge
Aug 12, 2008·Seminars in Oncology·Claudia D Baldus, Lars Bullinger
Aug 22, 2008·Blood·Klaus H MetzelerUNKNOWN German AML Cooperative Group
Sep 25, 2009·The New England Journal of Medicine·Hugo F FernandezMartin S Tallman
Dec 3, 2009·Haematologica·Sophie ParkDidier Bouscary
Dec 4, 2010·Proceedings of the National Academy of Sciences of the United States of America·Clare G FedeleChristina A Mitchell
Nov 11, 2011·Genes, Chromosomes & Cancer·Catarina LundinBertil Johansson
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
May 3, 2013·The New England Journal of Medicine·UNKNOWN Cancer Genome Atlas Research NetworkGreg Eley
Aug 1, 2013·Physiological Reviews·Tamas Balla
Nov 30, 2013·The Journal of Investigative Dermatology·Rolando Perez-LorenzoBasil A Horst
Dec 3, 2014·Molecular Cell·Jessica A GasserAlex Toker

❮ Previous
Next ❯

Citations

Nov 18, 2015·The FEBS Journal·Andrés Alonso, Rafael Pulido
Sep 29, 2015·Oncogene·S T GuoC C Jiang
Jul 8, 2015·Trends in Molecular Medicine·John F WoolleyLeonardo Salmena
Oct 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ping WangYan Li
Aug 18, 2016·Biochemical and Biophysical Research Communications·Wen-Liang TianLing Sun
May 2, 2015·Blood·Christian Recher
Dec 30, 2016·Molecular and Cellular Biology·Elizabeth A Sierra PotchanantGrzegorz Nalepa
Jan 19, 2018·Journal of Experimental & Clinical Cancer Research : CR·Hongjun JinLing Zhang
Mar 23, 2019·Bioscience Reports·Chunxia LiuLi Zhao
Jan 14, 2017·Bioscience Reports·Samuel J RodgersLisa M Ooms
Oct 21, 2015·Oncotarget·Fernando N BralhaRebecca R Laposa
Mar 12, 2020·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Maha El TaweelRafaat Abdelfattah
Nov 7, 2019·Oncotarget·Emily Marie MangialardiLeonardo Salmena
Mar 17, 2019·Biological Research·Feng ZhangPingping Zhang
Apr 17, 2020·Frontiers in Oncology·Luca GozzelinoMiriam Martini
Apr 26, 2020·Molecular Biology Reports·Ningni JiangJuan Peng
Mar 31, 2021·Drug Discovery Today·Mehrdad IzadiradZhe-Sheng Chen
Mar 5, 2018·Experimental Cell Research·Wen-Liang TianLing Sun
May 27, 2021·Nature Communications·Samuel J RodgersChristina A Mitchell
Jul 4, 2021·Advances in Biological Regulation·Sabryn A HamilaChristina A Mitchell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.